A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy

Przemyslaw W. Twardowski, Jan H. Beumer, C. S. Chen, Andrew S. Kraft, Gurkamal S. Chatta, Masato Mitsuhashi, Wei Ye, Susan M. Christner, Michael B. Lilly

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences